List of Excipients in API MELPHALAN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MELPHALAN
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | CROSPOVIDONE | |
ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | HYPROMELLOSE | |
ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | MAGNESIUM STEARATE | |
ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | MICROCRYSTALLINE CELLULOSE | |
ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | POLYETHYLENE GLYCOL 400 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing MELPHALAN
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Alvogen Inc | melphalan usp, 2 mg | 47781-200 | CELLULOSE, MICROCRYSTALLINE |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 | CROSPOVIDONE |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 | HYPROMELLOSE |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 | MAGNESIUM STEARATE |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 | POLYETHYLENE GLYCOL |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for MELPHALAN
Excipient focus: BETADEX
MELPHALAN drug variants containing BETADEX
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing BETADEX
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
MELPHALAN drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Acrotech Biopharma LLC | melphalan | 68152-109 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
MELPHALAN drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
MELPHALAN drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
MELPHALAN drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
MELPHALAN drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE
MELPHALAN drug variants containing MICROCRYSTALLINE CELLULOSE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing MICROCRYSTALLINE CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
MELPHALAN drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
MELPHALAN drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
MELPHALAN drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
MELPHALAN drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ApoPharma USA Inc | melphalan | 52609-0001 |
Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
>Company | >Ingredient | >NDC |
MELPHALAN drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Acrotech Biopharma LLC | melphalan | 68152-109 |
Acrotech Biopharma Inc | melphalan | 72893-001 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.